In the last trading session, 1.06 million shares of the Alector Inc (NASDAQ:ALEC) were traded, and its beta was 0.81. Most recently the company’s share price was $1.08, and it changed around $0.1 or 10.11% from the last close, which brings the market valuation of the company to $107.01M. ALEC currently trades at a discount to its 52-week high of $6.78, offering almost -527.78% off that amount. The share price’s 52-week low was $0.87, which indicates that the current value has risen by an impressive 19.44% since then. We note from Alector Inc’s average daily trading volume that its 10-day average is 0.73 million shares, with the 3-month average coming to 640.89K.
Alector Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.12. If we narrow it down even further, the data shows that 1 out of 9 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended ALEC as a Hold, whereas 5 deemed it a Buy, and 1 rated it as Underweight. Alector Inc is expected to report earnings per share of -0.46 for the current quarter.
Alector Inc (NASDAQ:ALEC) trade information
Instantly ALEC has showed a green trend with a performance of 10.11% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.0850 on recent trading dayincreased the stock’s daily price by 0.46%. The company’s shares are currently down -42.86% year-to-date, but still up 14.61% over the last five days. On the other hand, Alector Inc (NASDAQ:ALEC) is -21.74% down in the 30-day period. We can see from the shorts that 5.44 million shares have been sold at a short interest cover period of 7.28 day(s).
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to increase their stock price by 73.0% from its current value. Analyst projections state that ALEC is forecast to be at a low of $4 and a high of $4.
Alector Inc (ALEC) estimates and forecasts
The year-over-year growth rate is expected to be -85.95%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 4.25M in revenue for the current quarter. 2 analysts expect Alector Inc to make 4.25M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 15.89M and 15.08M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -73.26%. Forecasts for the next quarter put sales growth at -71.82%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 6.31%. Alector Inc earnings are expected to increase by -63.83% in 2025, but the outlook is positive 4.34% per year for the next five years.
ALEC Dividends
Alector Inc’s next quarterly earnings report is expected to be released on 2025-Feb-25.
Alector Inc (NASDAQ:ALEC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.71% of Alector Inc shares, and 82.53% of them are in the hands of institutional investors. The stock currently has a share float of 92.43%. Alector Inc stock is held by 219.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 14.9545% of the shares, which is about 14.46 million shares worth $65.64 million.
BLACKROCK INC., with 9.4145% or 9.1 million shares worth $41.32 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and Fidelity Select Portfolios-Biotechnology Portfolio were the top two Mutual Funds as of Feb 28, 2025 . The former held 3.62 shares worth $3.91 million, making up 3.66% of all outstanding shares. On the other hand, Fidelity Select Portfolios-Biotechnology Portfolio held roughly 3.54 shares worth around $3.82 million, which represents about 3.57% of the total shares outstanding.
